Dr. Greg Plotnikoff has spent more than a decade evangelizing about the health benefits of vitamin D to his medical colleagues across the globe.
Now the Allina Health doctor is turning to corporate America, hoping his message will have new resonance amid soaring medical costs and a fragile economic recovery.
Because vitamin D is believed to be effective at treating or preventing such conditions as low-back pain, allergies, migraines, high blood pressure and depression, Plotnikoff argues that the inexpensive pills can play a key role in reducing "presenteeism," where employees show up for work but don't get much done. Some studies say the problem costs U.S. employers more than $150 billion a year.
In a soon-to-be published study, Plotnikoff, an internist and pediatrician, argues that companies can save $112 to $370 per employee per year in preventable illness and improved productivity simply by encouraging workers to boost their vitamin D.
"Vitamin D may represent the single most cost-effective medical intervention we have today," he said.
Vitamin D has long been considered essential to helping the body absorb calcium, which is important for strong bones. But Plotnikoff and other researchers have argued in recent years that higher doses could also help protect against cancer, heart disease, diabetes, osteoporosis, mental illnesses and autoimmune diseases, such as multiple sclerosis.
Not everyone is convinced. A report by the Institute of Medicine in November 2010 noted mixed results in more than 1,000 published studies. But the group said the possible health benefits warrant further investigation.
Boston's Dr. Ravi Thadhani, who is researching the role of vitamin D in heart and kidney disease, said "it's very attractive" to hang medical hopes on vitamin D. But robust scientific evidence isn't there yet.